Dachaigh › Leukemia Lymphocytic Cronach › Nebraska › Omaha
Sgrùdaidhean clionaigeach Leukemia Lymphocytic Cronach ann an Omaha, NE
Tha 8 sgrùdaidhean airson Leukemia Lymphocytic Cronach a’ lorg phàirtichean aig làraichean ann agus timcheall air Omaha (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
A’ fastadhÌre 3
- Oncology Hematology West, Pc Dba Nebraska Cancer Specialists, Omaha
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
A’ fastadhÌre 3
- University of Nebraska Medical Center, Omaha
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A’ fastadhÌre 3
- University of Nebraska Medical Center, Omaha
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
A’ fastadhÌre 1
- University of Nebraska Medical Center, Omaha
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
A’ fastadhÌre 1/2
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A’ fastadhÌre 4
- University Of Nebraska Medical Center, Omaha
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
A’ fastadhÌre 4
- University Of Nebraska Medical Center, Omaha
Sgrùdaidhean Leukemia Lymphocytic Cronach ann am bailtean eile
- Boston, MA31 sgrùdaidhean
- Columbus, OH28 sgrùdaidhean
- Durham, NC27 sgrùdaidhean
- Washington, DC22 sgrùdaidhean
- Seattle, WA20 sgrùdaidhean
- Rochester, MN18 sgrùdaidhean
- New York City, NY18 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Baldwin Park, CA16 sgrùdaidhean
- Milwaukee, WI15 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Cincinnati, OH14 sgrùdaidhean
Sgrùdaidhean eile ann an Omaha
- Aillse Prostata27 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag24 sgrùdaidhean
- Aillse a' bhroilleach22 sgrùdaidhean
- Aillse (gach seòrsa)18 sgrùdaidhean
- Aillse colorectal18 sgrùdaidhean
- Myeloma iomaill16 sgrùdaidhean
- Cancer Ovarian14 sgrùdaidhean
- Liomfoma Neo-Hodgkin14 sgrùdaidhean
- Cancer Pancreatic14 sgrùdaidhean
- Ailse metastatach13 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil13 sgrùdaidhean
- Fàilligeadh a' Chridhe13 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.